rs17552682
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001177693.2(ARHGEF28):c.267G>A(p.Val89=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0115 in 1,613,496 control chromosomes in the GnomAD database, including 177 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 13 hom., cov: 32)
Exomes 𝑓: 0.012 ( 164 hom. )
Consequence
ARHGEF28
NM_001177693.2 synonymous
NM_001177693.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.16
Genes affected
ARHGEF28 (HGNC:30322): (Rho guanine nucleotide exchange factor 28) This gene encodes a member of the Rho guanine nucleotide exchange factor family. The encoded protein interacts with low molecular weight neurofilament mRNA and may be involved in the formation of amyotrophic lateral sclerosis neurofilament aggregates. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 5-73752994-G-A is Benign according to our data. Variant chr5-73752994-G-A is described in ClinVar as [Benign]. Clinvar id is 257365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-73752994-G-A is described in Lovd as [Benign]. Variant chr5-73752994-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.15 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00877 (1336/152334) while in subpopulation SAS AF= 0.0195 (94/4822). AF 95% confidence interval is 0.0163. There are 13 homozygotes in gnomad4. There are 643 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF28 | NM_001177693.2 | c.267G>A | p.Val89= | synonymous_variant | 4/36 | ENST00000513042.7 | NP_001171164.1 | |
ARHGEF28 | NM_001080479.3 | c.267G>A | p.Val89= | synonymous_variant | 4/37 | NP_001073948.2 | ||
ARHGEF28 | NM_001388078.1 | c.267G>A | p.Val89= | synonymous_variant | 4/35 | NP_001375007.1 | ||
ARHGEF28 | NM_001388076.1 | c.181+3010G>A | intron_variant | NP_001375005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF28 | ENST00000513042.7 | c.267G>A | p.Val89= | synonymous_variant | 4/36 | 5 | NM_001177693.2 | ENSP00000441436 |
Frequencies
GnomAD3 genomes AF: 0.00876 AC: 1334AN: 152216Hom.: 13 Cov.: 32
GnomAD3 genomes
AF:
AC:
1334
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0108 AC: 2665AN: 247902Hom.: 33 AF XY: 0.0118 AC XY: 1583AN XY: 134464
GnomAD3 exomes
AF:
AC:
2665
AN:
247902
Hom.:
AF XY:
AC XY:
1583
AN XY:
134464
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0118 AC: 17245AN: 1461162Hom.: 164 Cov.: 31 AF XY: 0.0123 AC XY: 8953AN XY: 726782
GnomAD4 exome
AF:
AC:
17245
AN:
1461162
Hom.:
Cov.:
31
AF XY:
AC XY:
8953
AN XY:
726782
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00877 AC: 1336AN: 152334Hom.: 13 Cov.: 32 AF XY: 0.00863 AC XY: 643AN XY: 74486
GnomAD4 genome
AF:
AC:
1336
AN:
152334
Hom.:
Cov.:
32
AF XY:
AC XY:
643
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at